MARKET

VRPX

VRPX

Virpax Pharmaceuticals Inc
EXMKT
0.011
NaN%
Closed 09:30 02/12 EST
OPEN
--
PREV CLOSE
0.011
HIGH
--
LOW
--
VOLUME
--
TURNOVER
--
52 WEEK HIGH
104.28
52 WEEK LOW
0.010
MARKET CAP
14.19K
P/E (TTM)
-0.0039
1D
5D
1M
3M
1Y
5Y
1D
Weekly Report: what happened at VRPX last week (0202-0206)?
Weekly Report · 4d ago
Weekly Report: what happened at VRPX last week (0126-0130)?
Weekly Report · 02/02 09:39
Weekly Report: what happened at VRPX last week (0119-0123)?
Weekly Report · 01/26 09:39
Weekly Report: what happened at VRPX last week (0112-0116)?
Weekly Report · 01/19 09:43
Weekly Report: what happened at VRPX last week (0105-0109)?
Weekly Report · 01/12 09:42
Weekly Report: what happened at VRPX last week (1229-0102)?
Weekly Report · 01/05 09:39
Weekly Report: what happened at VRPX last week (1222-1226)?
Weekly Report · 12/29/2025 09:38
Weekly Report: what happened at VRPX last week (1215-1219)?
Weekly Report · 12/22/2025 09:38
More
About VRPX
Virpax Pharmaceuticals, Inc. is a preclinical-stage pharmaceutical company. The Company is focused on developing novel and proprietary drug delivery systems across various pain indications. Its drug-delivery systems and drug-releasing technologies being developed are focused on advancing non-opioid and non-addictive pain management treatments and treatments for central nervous system (CNS) disorders to enhance patients’ quality of life. Its portfolio consists of multiple preclinical stage product candidates: Epoladerm, Probudur, Envelta, AnQlar and NobrXiol. Probudur is a single injection liposomal bupivacaine formulation being developed to manage post-operative pain. Envelta is an intranasal molecular envelope enkephalin formulation being developed to manage acute and chronic pain, including pain associated with cancer. The NobrXiol is being developed for the nasal delivery of a pharmaceutical grade cannabidiol (CBD) for the management of rare pediatric epilepsy.

Webull offers Virpax Pharmaceuticals Inc stock information, including EXMKT: VRPX real-time market quotes, financial reports, professional analyst ratings, in-depth charts, corporate actions, VRPX stock news, and many more online research tools to help you make informed decisions. Trade stocks for 0 commission and 0 contract fees on the web version for easy and convenient access, or download the Webull app and trade on the go.

You can practice and explore trading VRPX stock methods without spending real money on the virtual paper trading platform.